Type 2 Diabetes Screening and Treatment Guideline PDF - Overview
Type 2 Diabetes Screening and Treatment Guideline – Type 2 diabetes is an impairment in the way the body regulates and uses sugar (glucose) as a fuel. This long-term (chronic) condition results in too much sugar circulating in the bloodstream. Eventually, high blood sugar levels can lead to disorders of the circulatory, nervous and immune systems.
Type 2 Diabetes Screening and Treatment Guideline
Contents of Type 2 Diabetes Screening and Treatment Guideline
- Interim Update September 2021
- Changes as of March 2021
- Prevention
- Screening and Tests
- Diagnosis
- Treatment
- Risk-reduction goals
- Lifestyle modifications and non-pharmacologic options
- Bariatric surgery
- Pharmacologic options for glucose control
- Type 2 diabetes treatment workflow for Primary Care
- Type 2 diabetes treatment: when to consider glargine or U-500 insulin
- Additional pharmacologic options to consider in consultation with Diabetes Team
- Pharmacologic options that are not recommended
- Referral to Nursing or Clinical Pharmacy
- Follow-up and Monitoring
- Self blood glucose monitoring
- Periodic monitoring of conditions and complications
- Medication monitoring
- Recommended immunizations
- Comorbidities
- Evidence Summary
- References
- Guideline Development Process and Team
- Last guideline approval: March 2021
Diagnosis
| Test | Result | Interpretation |
|---|---|---|
| HBA1c | 6.5% or Higher | Diabetes |
| 5.7-6.4% | Impaired Glucose Tolerance | |
| Lower than 5.7% | Normal | |
| Random Plasma Glucose | 200 Mg/Dl or Higher | Diabetes |
| 140-199 Mg/Dl | Impaired Glucose Tolerance | |
| Lower than 140 Mg/Dl | Normal | |
| Fasting Plasma Glucose | 126 Mg/Dl or Higher | Diabetes |
| 100-125 Mg/Dl | Impaired Glucose Tolerance | |
| Lower than 100 Mg/Dl | Normal |